收稿日期: 2021-08-15
网络出版日期: 2024-10-16
版权
Rheumatoid arthritis with Castleman-like histopathology in lymph nodes: A case report
Received date: 2021-08-15
Online published: 2024-10-16
Copyright
刘东武 , 陈杰 , 高明利 , 于静 . 类风湿关节炎伴发淋巴结Castleman样病理改变1例[J]. 北京大学学报(医学版), 2024 , 56(5) : 928 -931 . DOI: 10.19723/j.issn.1671-167X.2024.05.028
Rheumatoid arthritis (RA) is a common chronic autoimmune inflammatory disease, characterized by persistent polyarthritis. Patients with RA may exhibit varying degrees of B lymphocyte activation, clinically manifested as enlarged lymph nodes. Disease-modifying anti-rheumatic drugs and glucocorticoid are often used to treat RA. Biological agents targeting tumor necrosis factor alpha, interleukin-6(IL-6), and B lymphocytes are often used to treat rheumatoid arthritis. Castleman disease (CD) is a rare benign lymphoproliferative disorder. Histopathological examination is the most important method to diagnose this disease. Based on the different lymph node involvement areas CD can be divided into unicentric CD(UCD) and multicentric CD(MCD). Surgical removal of lymph nodes is a common treatment method for UCD. MCD often requires chemotherapeutic drugs combined with glucocorticoid therapy. For the most recent years, biological agents targeting IL-6 and B lymphocytes have shown good curative effects on CD. In the past, patients with rheumatic immune disease accompanied by Castleman like histopathology in lymph nodes were commonly referred to as rheumatic immune disease combined with CD. In 2021, experts unanimously agreed that autoimmune diseases with Castleman like lymphadenopathy should be diagnosed as rheumatic autoimmune diseases with Castleman like histopathology in lymph nodes. This report introduces a 65-year-old female patient with rheumatoid arthritis who was admitted to the hospital due to joint swelling and pain. Physical and chemical examinations after admission showed that rheumatoid arthritis was in an active phase. Chest CT revealed multiple enlarged lymph nodes in the right armpit. Then it was removed by surgery. The histopathological report showed that the lymphatic sinus disappeared, the lymphoid tissue proliferated, the lymphoid follicles increased, and the size was inconsistent. The small lymphocytes around the germinal centers of some follicles were concentric circles, and the follicular interstitial blood vessels proliferated. She was diagnosed with rheumatoid arthritis with Castleman like histopathology in lymph nodes and was treated with methotrexate and hydroxychloroquine sulfate combined with glucocorticoids. The patient was followed up for 2 years. In the first year after sur-gery, the patient' s condition remained stable and there was no growth of lymph nodes in the right axilla. The patient passed away due to severe infection in the second year after the surgery.
| 1 | Demirkan FG , Do?an S , Kalyoncu U?ar A , et al. Systemic lupus erythematosus complicated with Castleman disease: A case-based review[J]. Rheumatol Int, 2021, 41 (2): 475- 479. |
| 2 | Minemura H , Tanino Y , Ikeda K . Possible association of multicentric Castleman' s disease with autoimmune lymphoproliferative syndrome[J]. Biores Open Access, 2018, 7 (1): 47- 51. |
| 3 | Tabata S , Higuchi T , Tatsukawa S , et al. Idiopathic multicentric Castleman disease with autoimmune hemolytic anemia and production of anti-drug antibody against tocilizumab[J]. Intern Med, 2019, 58 (22): 3313- 3318. |
| 4 | 中华医学会血液学分会淋巴细胞疾病学组, 中国抗癌协会血液肿瘤专业委员会, 中国Castleman病协作组. 中国Castleman病诊断与治疗专家共识(2021年版)[J]. 中华血液学杂志, 2021, 42 (7): 529- 534. |
| 5 | 郑东辉, 莫颖倩, 戴冽, 等. 类风湿关节炎不同滑膜淋巴细胞分布类型的临床病理特点[J]. 中山大学学报(医学科学版), 2009, 30 (5): 571- 576. |
| 6 | 张玲玲, 魏伟. BAFF/BAFF-R通过PI3K/Akt/mTOR信号转导通路调节B淋巴细胞功能在类风湿关节炎发病机制中的意义[J]. 中国药理学通报, 2010, 26 (7): 847- 850. |
| 7 | Picemo V , Ferro F , Adinolfi A , et al. One year in riview: The pathogenesis of rheumatoid arthritis[J]. Clin Exp Rheumatol, 2015, 33 (4): 551- 558. |
| 8 | 唐果, 龙丽, 韩雅欣, 等. 类风湿关节炎合并结核感染的临床特点及相关因素[J]. 北京大学学报(医学版), 2020, 52 (6): 1029- 1033. |
| 9 | 刘娣, 郭万珍, 蔡华聪, 等. 类风湿关节炎并发淋巴瘤的临床特征[J]. 中华临床免疫和变态反应杂志, 2015, 9 (4): 292- 296. |
| 10 | Castleman B , Towne V . Case records of the Massachusetts General Hospital weekly clinicopathological exercises: Case 40011[J]. N Engl J Med, 1954, 250 (1): 26- 30. |
| 11 | Wang HW , Pittaluga S , Jaffe ES . Multicentric Castleman disease: Where are we now?[J]. Semin Diagn Pathol, 2016, 33 (5): 294- 306. |
| 12 | Nguyen D , Diamond L , Hansmann N , et al. Castleman' s disease. Differences in follicular dendritic network in the hyaline vascular and plasma cell variants[J]. Histopathology, 1994, 24 (5): 437- 443. |
| 13 | Herrada J , Cabanillas F , Rice L , et al. The clinical behavior of localized and multicentric Castleman disease[J]. Ann Intern Med, 1998, 128 (8): 657- 662. |
| 14 | Peterson B , Frizzera G . Multicentric Castleman' s disease[J]. Semin Oncol, 1993, 20 (6): 636- 647. |
| 15 | Frizzera G , Peterson BA , Bayrd ED , et al. A systemic lymphoproliferative disorder with morphologic features of Castleman' s disease: Clinical findings and clinicopathologic correlations in 15 patients[J]. J Clin Oncol, 1985, 3 (9): 1202- 1216. |
| 16 | Bowne WB , Lewis JJ , Filippa DA , et al. The management of unicentric and multicentric Castleman' s disease: A report of 16 cases and a review of the literature[J]. Cancer, 1999, 85 (3): 706- 717. |
| 17 | Nishimoto N , Kanakura Y , Aozasa K , et al. Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease[J]. Blood, 2005, 106 (8): 2627- 2632. |
| 18 | Casper C , Voorhees PM , Fayad LE , et al. An open-label, phase 2, multicenter study of the safety of long-term treatment with siltuximab (an anti-interleukin-6 monoclonal antibody) in patients with multicentric Castleman' s disease[J]. Blood, 2013, 122 (21): 1806. |
| 19 | de Marchi G , de Vita S , Fabris M , et al. Systemic connective tissue disease complicated by Castleman' s disease: Report of a case and review of the literature[J]. Haematologica, 2004, 89 (4): 7- 10. |
| 20 | Jacobs SA , Vidnovic N , Patel H , et al. Durable remission of HIV-negative, Kaposi' s sarcoma herpes virus-associated multicentric Castleman disease in patient with rheumatoid arthritis treated with methotrexate[J]. Clin Rheumatol, 2007, 26 (7): 1148- 1150. |
| 21 | Sun Y , Wang D , Salvadore G , et al. The effects of interleukin-6 neutralizing antibodies on symptoms of depressed mood and anhedonia in patients with rheumatoid arthritis and multicentric Castle-man' s disease[J]. Brain Behav Immun, 2017, 66 (11): 156- 164. |
/
| 〈 |
|
〉 |